Added Value of Magnetic Resonance Imaging in Staging of Malignant Pleural Mesothelioma |
Lee, Eunsol
(Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center)
Chae, Eun Jin (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Kang, Sunji (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Yeom, Yoo Kyeong (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Lee, Hyun Joo (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Park, Jong Chun (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Shin, So Youn (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Choi, Yoon Young (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Choi, Joon Ho (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) Do, Kyung-Hyun (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) |
1 | Neumann V, Loseke S, Nowak D, Herth FJ, Tannapfel A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int 2013;110: 319-326 |
2 | Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14 DOI ScienceOn |
3 | Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev 2008;17:525- 534 DOI ScienceOn |
4 | Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004; 159:107-112 DOI ScienceOn |
5 | Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 2011;89:716-724 DOI ScienceOn |
6 | Cao C, Tian DH, Pataky KA, Yan TD. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer 2013;81:319-327 DOI ScienceOn |
7 | Erasmus JJ, Truong MT, Smythe WR, et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 2005; 129:1364-1370 DOI ScienceOn |
8 | Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479-495 DOI ScienceOn |
9 | Martino D, Pass HI. Integration of multimodality approaches in the management of malignant pleural mesothelioma. Clin Lung Cancer 2004;5:290-298 DOI ScienceOn |
10 | Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63 DOI ScienceOn |
11 | Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 2013;145:909-910 DOI ScienceOn |
12 | Nowak AK. CT, RECIST, and malignant pleural mesothelioma. Lung Cancer 2005;49 Suppl 1:S37-40 |
13 | Patz EF, Jr., Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992;159:961-966 DOI ScienceOn |
14 | Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999;172:1039- 1047 DOI ScienceOn |
15 | Wang ZJ, Reddy GP, Gotway MB, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004;24:105-119 DOI ScienceOn |
16 | Plathow C, Staab A, Schmaehl A, et al. Computed tomography, positron emission tomography, positron emission tomography/ computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Invest Radiol 2008;43:737-744 DOI ScienceOn |
17 | Boiselle PM, Patz EF, Jr., Vining DJ, Weissleder R, Shepard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics 1998;18:1061-1069 DOI ScienceOn |
18 | Karabulut N, Martin DR, Yang M, Tallaksen RJ. MR imaging of the chest using a contrast-enhanced breath-hold modified threedimensional gradient-echo technique: comparison with twodimensional gradient-echo technique and multidetector CT. AJR Am J Roentgenol 2002;179:1225-1233 DOI ScienceOn |
19 | Kajiwara N, Akata S, Uchida O, et al. Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion. Lung Cancer 2010;69:203-208 DOI ScienceOn |
20 | Zahid I, Sharif S, Routledge T, Scarci M. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg 2011;12:254-259 DOI |
21 | Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group Chest 1995;108:1122-1128 |
22 | Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-772 DOI ScienceOn |
23 | Datta A, Smith R, Fiorentino F, Treasure T. Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position. Thorax. 2013 Epub |
24 | Gill RR. Imaging of mesothelioma. Recent Results Cancer Res 2011;189:27-43 DOI ScienceOn |
25 | Gill RR, Gerbaudo VH, Jacobson FL, et al. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am 2008;16:319-339 DOI ScienceOn |
26 | Hintze C, Dinkel J, Biederer J, Heussel CP, Puderbach M. New procedures. Comprehensive staging of lung cancer by MRI. Radiologe 2010;50:699-705 DOI |
27 | Donmez FY, Yekeler E, Saeidi V, Tunaci A, Tunaci M, Acunas G. Dynamic contrast enhancement patterns of solitary pulmonary nodules on 3D gradient-recalled echo MRI. AJR Am J Roentgenol 2007;189:1380-1386 DOI ScienceOn |
28 | Lee VS, Lavelle MT, Krinsky GA, Rofsky NM. Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin N Am 2001;9:697-716 |
29 | Weber U, Lambert RG, Rufibach K, et al. Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study. Arthritis Res Ther 2012;14:R3 DOI ScienceOn |